Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

4.27
Delayed Data
As of 1:52pm ET
 +0.04 / +0.95%
Today’s Change
2.85
Today|||52-Week Range
9.40
-9.17%
Year-to-Date
Mirati Skyrockets On Positive Data - Biotech Movers
Sep 15 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close4.23
Today’s open4.21
Day’s range4.21 - 4.29
Volume11,877
Average volume (3 months)154,584
Market cap$31.8M
Dividend yield--
Data as of 1:52pm ET, 09/21/2017

Growth & Valuation

Earnings growth (last year)+46.12%
Earnings growth (this year)+80.38%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
ADHDAlcobra Ltd+0.03+2.78%
CTXRCitius Pharmaceutica...+0.04+1.26%
VKTXViking Therapeutics ...-0.01-1.20%
ITEKInotek Pharmaceutica...+0.10+7.09%
Data as of 2:11pm ET, 09/21/2017

Financials

Next reporting dateNovember 10, 2017
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$0.00
Annual profit (last year)-$38.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Seth Lederman
Chief Financial Officer
Bradley Saenger
Corporate headquarters
New York, New York

Forecasts